Halozyme Loses Temporary Ban on Merck’s Under-the-Skin Keytruda in Germany

German court overturns ban on Merck’s under-the-skin Keytruda. Halozyme plans full lawsuit seeking permanent relief amid ongoing patent dispute.

Halozyme Loses Temporary Ban on Merck’s Under-the-Skin Keytruda in Germany
Credit: Merck
Already have an account? Sign in.